HMR PHARMA, INC. – Trademark Portfolio
Entity Type: 03
HMR PHARMA, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CARAFATE, NICODERM, OS-CAL ULTRA, and MANAGED CARE DIGEST SERIES. The owner is based in GREENVILLE, DE.
3711 KENNETT PIKE
SUITE 200
GREENVILLE, DE 19807
Showing of trademarks Trademarks
Trademark Classifications
HMR PHARMA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does HMR PHARMA, INC. have?
HMR PHARMA, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 5 cancelled.
What trademark classes does HMR PHARMA, INC. file in?
HMR PHARMA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 38 (Telecommunications). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HMR PHARMA, INC.'s most well-known trademarks?
HMR PHARMA, INC.'s registered trademark portfolio includes well-known marks such as CARAFATE, NICODERM, OS-CAL ULTRA, and MANAGED CARE DIGEST SERIES. These are among 4 currently registered trademarks in the portfolio.
What is HMR PHARMA, INC.'s trademark registration success rate?
HMR PHARMA, INC. has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.